Sign in

CIK 0001430306

  • Non-accelerated filer
  • Smaller reporting company

Tonix Pharmaceuticals Holding Corp.

Sign in to watch
Ticker
TNXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
261434750
Phone
+1 212-980-9155
Business address
200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
Former names
TAMANDARE EXPLORATIONS INC.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market buy Chief Executive Officer bought 5,000 shares at $2.49 ($12,440)
  4. 4 Open-market buy Chief Executive Officer bought 25,000 shares at $2.38 ($59,375)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 4 Open-market buy Chief Executive Officer bought 500 shares at $4.64 ($2,320)
  14. 4 Open-market buy Chief Executive Officer bought 500 shares at $4.58 ($2,290)
  15. 4 Open-market buy Chief Executive Officer bought 500 shares at $4.55 ($2,275)
  16. 4 Open-market buy Director bought 16,500 shares at $4.48 ($73,920)
  17. 4 Open-market buy Chief Medical Officer bought 10,000 shares at $3.97 ($39,650)
  18. 4 Open-market buy Chief Executive Officer bought 3,000 shares at $4.37 ($13,110)
  19. 4 Open-market buy Chief Financial Officer bought 300 shares at $4.10 ($1,230)
  20. 4 Open-market buy Chief Operating Officer bought 300 shares at $4.19 ($1,257)

Page 8 of 19 · 376 filings